Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Diseases

Explore clinical trials studying Central Nervous System Diseases. Study availability and eligibility vary by location and protocol.

300 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Diseases trial results

Active, not recruiting

International Subarachnoid Aneurysm Trial II

NCT01668563

Conditions
Aneurysm, Brain Diseases, Cardiovascular Diseases, +7 more
Locations
  • Montefiore Medical Center The Bronx, New York, United States
  • Foothills Medical Centre Calgary, Alberta, Canada
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Centre Hospitalier de l'Université de Montréal - Hôpital Notre Dame Montreal, Quebec, Canada
View Trial Details
Active, not recruiting

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease

NCT04519749

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
  • Lysosomal & Rare Disorders Research & Treatment Center, Inc Fairfax, Virginia, United States
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)

NCT03694275

Conditions
15q Duplication Syndrome, Autism Spectrum Disorder, Autistic Disorder, +10 more
Locations
  • UCLA Los Angeles, California, United States
  • Research Institute Children's Hospital Colorado Aurora, Colorado, United States
  • Center for Rare Neurological Diseases Norcross, Georgia, United States
  • Center for Rare Neurological Diseases (CRND)--Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions